companydata.dkcompanydata.dk

BioPartner Nordic ApS: Financial statements 2022

CVR: 38153188

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,217 and a net result of DKK -42,541 compared with DKK -10,713 the year before. Equity in the 2022 report amounted to DKK -115,346.

Gross Profit
DKK -13,217
Profit/Loss
DKK -42,541
Equity
DKK -115,346
Total Assets
DKK 28,834

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--13K-43K-115K-
2021121K23K-11K5K-
2020240K78K56K-62K-
201958K-137K-167K-118K-
2018587K185K185K50K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on BioPartner Nordic ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

BioPartner Nordic ApS: The 2021 annual report is outMay 5, 2022

BioPartner Nordic ApS has published its annual report for 2021. Revenue came to DKK 121,400, and the net result was DKK -10,713.

About BioPartner Nordic ApS

BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.

Source: annual report 2025, Danish Business Authority

Other financial years